CClinicalTrials.gg
Not yet recruitingNCT07520955SLEEP-TIESUpdated Aug 28, 2026

Lily's Grace Temporal Interference

An interventional study of TES-TI and Sham Stimulation in Epilepsy, sponsored by University of Wisconsin, Madison. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by University of Wisconsin, Madison · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study is to evaluate the effectiveness of targeted Transcranial Electrical Stimulation with Temporal Interference (TES-TI) interventions to boost Non-Rapid Eye Movement (NREM) sleep, decrease seizures and promote emotional health in patients with epilepsy. Up to 24 participants (8 control participants for technical optimization prior to recruitment and 16 patients with epilepsy) will be enrolled and can expect to be on study for up to 24 months.

Read the detailed description

This is a Phase I randomized, single-blind, cross-over feasibility study comprised of 16 participants. Each participant will undergo structural and functional MRI then complete four nights of TES-TI stimulation and four nights of sham stimulation in counterbalanced order, separated by ≥1 day between visits.

Conditions on each visit are randomized and counterbalanced. During each visit, participants will complete both the REST-Q and SSS questionnaires. Full HD-EEG will be applied as well as 4-16 stimulation electrodes. Participants will then undergo an emotion regulation task (face task) wherein they are presented with positive, negative, or neutral emotional stimuli.

This is followed by a resting HD-EEG recording, then overnight stimulation. Either sham or non-sham (8 patients in each group) stimuli will be applied at times during the sleep period. Upon waking, the same questionnaires and emotion regulation tasks will be completed.

Objectives:

  • Assess the efficacy of TES-TI to boost sleep NREM slow-wave activity and spindles in patients with epilepsy overnight
  • Assess the efficacy of TES-TI to improve sleep quality and mood (REST-Q) and sleepiness (sleepiness scale) after treatment (4 nights) vs. before
  • Assess the efficacy of TES-TI to improve emotion responses (face task) and vigilance (psychomotor vigilance task; PVT) after treatment (4 nights) vs. before
  • Assess the efficacy of TES-TI to improve restorative quality of sleep (REST-Q questionnaire) after treatment (4 nights) vs. before
  • Assess the efficacy of TES-TI to reduce seizure frequency (self-reported) after treatment (4 nights) vs. before
02

Conditions studied

  • Epilepsy

Keywords

  • seizures
  • non rapid eye movement sleep
03

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • English-speaking (able to provide consent and complete questionnaires)
  • Citizen or holding permanent resident status
  • History of refractory epilepsy with intractable seizures and/or cognitive decline

Exclusion criteria

Exclusion Criteria:

  • Any current or past history of neurological disorders or acquired neurological disease other than epilepsy (e.g. stroke, traumatic brain injury), including intracranial lesions
  • Current history of poorly controlled headaches including intractable or poorly controlled migraines
  • Any systemic illness or unstable medical condition that may cause a medical emergency in case of a provoked seizure (cardiac malformation, cardiac dysrhythmia, asthma, etc.)
  • Possible pregnancy or plan to become pregnant in the next 6 months
  • Any metal in the head
  • Any metal in the body
  • Any medical devices or implants (i.e. cardiac pacemaker, medication infusion pump, cochlear implant, vagal nerve stimulator) unless otherwise approved by the responsible MD
  • Dental implants
  • Permanent retainers
  • Claustrophobia (a fear of small or closed places)
  • Back problems that would prevent lying flat for several hours
  • Regular night-shift work (second or third shift)
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Sham Stimulation then Real Stimulation

    Each participant will undergo structural and functional MRI then eight nights of intervention with possible sham or non-sham stimulation conditions.

    Device: TES-TI · Other: Sham Stimulation · Other: Structural and Functional MRI

  • Experimental
    Real Stimulation then Sham Stimulation

    Each participant will undergo structural and functional MRI then eight nights of intervention with possible sham or non-sham stimulation conditions.

    Device: TES-TI · Other: Sham Stimulation · Other: Structural and Functional MRI

Interventions

  • DeviceTES-TI

    Real stimulation will take place on visits 2 - 5 or visits 6 - 10.

    Also known as: Transcranial Electrical Stimulation with Temporal Interference

  • OtherSham Stimulation

    Sham stimulation will take place on visits 2 - 5 or visits 6 - 10.

  • OtherStructural and Functional MRI

    After baseline night visit 1 and before intervention visits 2 - 10. MRI is used to help determine electrode placement.

    Also known as: EEG-fMRI, anatomic MRI

05

What researchers measure

Primary outcomes

  1. NREM Sleep Slow-Wave Activity Measured by High-Density EEG (delta power)

    To assess the effect of TES-TI on NREM sleep slow-wave activity during treatment (4 nights) vs. sham (4 nights), slow-wave activity will be measured by high-density EEG.

    Time frame: measured during 8 overnight visits, data collected up to 24 months on study

  2. Number of Seizures per week

    To assess the effect of TES-TI on incidence of seizures after treatment (4 nights) vs. sham (4 nights), participants will maintain a seizure diary. The self-reported number of seizures seizures per week for the first week and the first four-weeks post-intervention.

    Time frame: data collected at 4 time points up to 24 months on study, 1 month and 3 month follow up after completion of 4 nights treatment and 1 month and 3 month follow up after completion 4 nights sham condition

  3. Psychomotor Vigilance Task (PVT)

    The vigilance task will be used to assess the effect of TES-TI on performance after treatment (4 nights) vs. sham (4 nights). This is a computerized reaction time task where a participant is presented with a fixation point on a computer screen. At random, the fixation point will change appearance at which point the participant is to click a provided button as quickly as possible. The time it took to respond is recorded automatically by the computer program and will be reported as the result.

    Time frame: measured during 8 overnight visits, data collected up to 24 months on study

  4. Restorative Sleep Questionnaire (REST-Q)

    The REST-Q measure will be used to assess the effect of TES-TI on sleep quality and mood after treatment (4 nights) vs. sham (4 nights). It is a 9-item questionnaire assessing aspects of restorative sleep. Each item is scored on a 5-point Likert scale (1-light; 5-deep). Final scores are transformed to a scale of 0-100 here higher scores indicate more restorative sleep.

    Time frame: measured during 8 overnight visits, data collected up to 24 months on study

  5. Stanford Sleepiness Scale (SSS)

    The Stanford Sleepiness Scale will be used to assess sleepiness after treatment (4 nights) vs. sham (4 nights). SSS is a measure of subjective alertness on a 7-point scale (total range of scores from 1-7). A lower score on the scale indicates higher alertness.

    Time frame: measured during 8 overnight visits, data collected up to 24 months on study

  6. Emotional Processing Task (Face Task): Percent Correct

    The Face Task will be used to assess the effect of TES-TI on emotion response after treatment (4 nights) vs. sham (4 nights). This task involves viewing a series of emotionally charged images (60 positive, 60 negative, 60 neutral).

    Time frame: measured during 8 overnight visits, data collected up to 24 months on study

  7. Emotional Processing Task (Face Task): Percent Change in Reaction Time

    The Face Task will be used to assess the effect of TES-TI on emotion response after treatment (4 nights) vs. sham (4 nights). This task involves viewing a series of emotionally charged images (60 positive, 60 negative, 60 neutral).

    Time frame: measured during 8 overnight visits, data collected up to 24 months on study

06

Study locations

1 site
  • UW School of Medicine and Public Health
    Madison, Wisconsin 53792, United States
07

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07520955
Lead sponsor
University of Wisconsin, Madison
Collaborators
Lily's Fund for Epilepsy Research
Responsible party
Sponsor
First posted
Apr 9, 2026
Start date
Sep 2026 (estimated)
Primary completion
Sep 2028 (estimated)
Completion
Sep 2028 (estimated)
Last update
Aug 28, 2026

Study contacts

Melanie Boly, MD, PhD
Contact
boly@neurology.wisc.edu
608-263-4338
Beril Mat, MD
Contact
mat@wisc.edu
Melanie Boly, MD, PhD
principal investigator · UW School of Medicine and Public Health

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion